The law firm of Kirby McInerney LLP announced today an investigation on behalf of investors of Trinity Biotech plc concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.

NEW YORK, NY / ACCESSWIRE / April 27, 2017 / Trinity Biotech Plc Sponsored ADR Class A (NASDAQ: TRIB) will be discussing their earnings results in their Q1 Earnings Call to be held April 27, 2017 at 11:00 ...